Publications by authors named "Anna Zommer"

Claim this Profile
I
Inhibition of the transcriptional repressor complex Bcl-6/BCoR induces endothelial sprouting but does not promote tumor growth.
Elisabeth Buchberger, Dietmar Payrhuber, Miriam El Harchi, Branislav Zagrapan, Katharina Scheuba, Anna Zommer

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of the transcriptional repressor complex BCL-6/BCoR leads to nuclear aggregates distinct from classical aggresomes.
Elisabeth Buchberger, Miriam El Harchi, Dietmar Payrhuber, Anna Zommer, Dominic Schauer

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types.
Herwig P Moll, Thomas Maier, Anna Zommer, Thomas Lavoie, Christine Brostjan

Cytokine· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contamination with recombinant IFN accounts for the unexpected stimulatory properties of commonly used IFN-blocking antibodies.
Herwig P Moll, Harald Freudenthaler, Anna Zommer, Elisabeth Buchberger, Xiao-Hong Lin

Eur J Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing type I IFN antibodies trigger an IFN-like response in endothelial cells.
Herwig Peter Moll, Harald Freudenthaler, Anna Zommer, Elisabeth Buchberger, Christine Brostjan

J Immunol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retroviral targeting of proliferating endothelial cells.
Alexander Gornikiewicz, Anna Zommer, Raimund Jakesz, Michael Gnant, Christine Brostjan

Acta Biochim Pol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy.
Christine Brostjan, Anita Bayer, Anna Zommer, Alexander Gornikiewicz, Sebastian Roka

Cancer· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis